Pharmacotherapy for Obesity in Mood Disorders.
- Author:
Inki SOHN
1
;
Kyu Hang LEE
Author Information
1. Keyo Hospital, Uiwang, Korea. fiveway@daum.net
- Publication Type:Review
- Keywords:
Mood disorder;
Obesity;
Pharmacotherapy
- MeSH:
Bupropion;
Drug Therapy*;
Metformin;
Mood Disorders*;
Mortality;
Obesity*;
Overweight;
Prevalence
- From:Korean Journal of Psychosomatic Medicine
2014;22(2):63-70
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The prevalence of obesity and overweight is increasing in mood disorder, and it is connected to an increased cardiovascular mortality. Because of them, treatment for obesity may be an essential part of mood disorder treatment. Similar to the general population, non-pharmacological treatment such as correction of life habits should be considered first of all. If this approaches are fail, pharmacological treatment for obesity would be required as next step. Any drug for obesity is not approved officially in mood disorder. So approved drugs in general population, and drugs supported by several studies are prescribed in clinical settings. Several treatment guidelines for mood disorder and studies support that orlistat, metformin, topiramate and bupropion is effective and safe.
